Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 59
Filter
1.
Arch Endocrinol Metab ; 68: e230375, 2024 Feb 29.
Article in English | MEDLINE | ID: mdl-38427812

ABSTRACT

Differentiated thyroid carcinoma (DTC) accounts for most cases of thyroid cancer, and the heterogeneity of DTC requires that management decisions be taken by a multidisciplinary team involving endocrinologists, head and neck surgeons, nuclear medicine physicians, pathologists, radiologists, radiation oncologists, and medical oncologists. It is important for nonspecialists to recognize and refer patients with DTC who will benefit from a specialized approach. Recent advances in knowledge and changes in management of DTC call for the need to raise awareness on the part of these nonspecialist physicians, including general endocrinologists and medical oncologists at large. We provide an overview of diagnostic and therapeutic principles in DTC, especially those that bear direct implication on day-to-day management of these patients by generalists. Patients with DTC may be broadly categorized as having localized, locally persistent/recurrent, or metastatic disease. Current recommendations for DTC include a three-tiered system that classifies patients with localized disease into low, intermediate, or high risk of persistent or recurrent disease. Risk stratification should be performed at baseline and repeated on an ongoing basis, depending on clinical evolution. One of the overarching goals in the management of DTC is the need to personalize treatment by tailoring its modality and intensity according to ongoing prognostic stratification, evolving knowledge about the disease, and patient characteristics and preference. In metastatic disease that is refractory to radioactive iodine, thyroid tumors are being reclassified into molecular subtypes that better reflect their biological properties and for which molecular alterations can be targeted with specific agents.


Subject(s)
Adenocarcinoma , Thyroid Neoplasms , Humans , Thyroid Neoplasms/pathology , Iodine Radioisotopes/therapeutic use , Phenylurea Compounds , Prognosis
2.
Int Immunopharmacol ; 125(Pt B): 111155, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37951192

ABSTRACT

BACKGROUND: The worst outcomes linked to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been attributed to the cytokine storm, which contributes significantly to the immunopathogenesis of the disease. The mammalian target of rapamycin (mTOR) pathway is essential for orchestrating innate immune cell defense including cytokine production and is dysregulated in severe Coronavirus Disease 2019 (COVID-19) individuals. The individual genetic background might play a role in the exacerbated immune response. OBJECTIVE: In this study, we aimed to investigate the association between MTOR genetic variants and COVID-19 outcomes. METHODS: This study enrolled groups of individuals with severe (n = 285) and mild (n = 207) COVID-19 from Brazilian states. The MTOR variants, rs1057079 and rs2536, were genotyped. A logistic regression analysis and Kaplan-Meier survival curves were performed. We applied a genotyping risk score to estimate the cumulative contribution of the risk alleles. Tumor necrosis factor (TNF) and interleukin-6 (IL-6) plasma levels were also measured. RESULTS: The T allele of the MTOR rs1057079 variant was associated with a higher likelihood of developing the most severe form of COVID-19. In addition, higher levels of IL-6 and COVID-19 death was linked to the T allele of the rs2536 variant. These variants exhibited a cumulative risk when inherited collectively. CONCLUSIONS: These results show a potential pathogenetic role of MTOR gene variants and may be useful for predicting severe outcomes following COVID-19 infection, resulting in a more effective allocation of health resources.


Subject(s)
COVID-19 , Genetic Variation , TOR Serine-Threonine Kinases , Humans , COVID-19/genetics , COVID-19/immunology , COVID-19/mortality , COVID-19/pathology , Patient Acuity , Case-Control Studies , Male , Female , Adult , Middle Aged , Aged , Survival Analysis , Cytokines/blood , TOR Serine-Threonine Kinases/genetics
3.
Thyroid Res ; 16(1): 40, 2023 Sep 29.
Article in English | MEDLINE | ID: mdl-37773072

ABSTRACT

PURPOSE: Inconsistencies in the medical management of hypothyroidism have been reported between endocrinologists in different countries. This study aimed to identify the attitudes of Latin America thyroid specialists towards the use of thyroid hormones. METHODS: Online survey of members of the Latin America Thyroid Society. RESULTS: 81/446 (18.2%) completed the questionnaire. Levothyroxine (LT4) was the initial treatment of choice for all respondents. 56.8% would consider LT4 use in biochemically euthyroid patients: infertile women with elevated anti-thyroid antibodies (46.9%), resistant depression (17.3%) and growing goiter (12%). Most respondents preferred tablets (39.5%) over liquid formulations (21.0%) or soft gel capsules (22.2%) and would not consider switching formulations in patients with persistent symptoms. 39.5% would never use LT4 + liothyronine (LT3) combination therapy in symptomatic euthyroid patients, due to low quality evidence for benefit. 60.5% reported that persistence of symptoms despite normal TSH is rare (below 5% of patients) and its prevalence has been stable over the last five years. Psychosocial factors (84.0%), comorbidities (86.4%) and the patient unrealistic expectation (72.8%) were considered the top three explanations for this phenomenon. CONCLUSION: LT4 tablets is the treatment of choice for hypothyroidism. A significant proportion of respondents would use LT4 in some groups of euthyroid individuals, contrasting the recommendations of the major clinical practice guideline indications. LT4 + LT3 combination treatment in euthyroid symptomatic patients was considered by nearly 50%. Practices based on weak or absent evidence included use of thyroid hormones for euthyroid subjects by 56.8% of respondents and use of LT4 + LT3 treatment by 60.5% of respondents for patients with persistent symptoms. In contrast to many European countries, LATS respondents report a low and unchanged proportion of dissatisfied patients over the last five years.

4.
Arch Endocrinol Metab ; 67(6): e000657, 2023 Jun 19.
Article in English | MEDLINE | ID: mdl-37364155

ABSTRACT

Objective: The objective of the study was to determine how physicians in Brazil manage Graves' disease in different scenarios including extrathyroidal manifestations. Materials and methods: This study was conducted via a digital survey. The respondents (n = 573) answered multiple-choice questions based on a clinical case and variations of the case regarding laboratory and imaging evaluation, treatment choice, and follow-up. Results: The preferred initial treatment chosen by 95% of the respondents was ATD with a preferred treatment duration of 18-24 months. For 5% of the respondents, RAI was the initial treatment of choice. None of the respondents chose thyroidectomy. When presented with a patient with a desire for pregnancy in the near future, most respondents (69%) opted for ATD as the initial treatment. For a patient with signs of mild to moderate Graves' orbitopathy, ATD remained the initial therapy for 93.9% of the respondents. For patients initially treated with ATD with disease recurrence after ATD interruption, most respondents (60%) chose definitive treatment with RAI. A similar survey published in 2011 by Burch and cols. had results comparable to those of the present survey but with a higher proportion of respondents choosing RAI (45% in the 2011 survey versus 5% in the present survey). Conclusion: Brazilian endocrinologists choose ATD as the initial management of Graves' disease, and most choose RAI as a definitive treatment for a patient with relapse after ATD therapy.


Subject(s)
Graves Disease , Graves Ophthalmopathy , Pregnancy , Female , Humans , Graves Ophthalmopathy/drug therapy , Brazil , Antithyroid Agents/adverse effects , Endocrinologists , Graves Disease/drug therapy , Surveys and Questionnaires
5.
Arch. endocrinol. metab. (Online) ; 67(6): e000657, Mar.-Apr. 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1447270

ABSTRACT

ABSTRACT Objective: The objective of the study was to determine how physicians in Brazil manage Graves' disease in different scenarios including extrathyroidal manifestations. Materials and methods: This study was conducted via a digital survey. The respondents (n = 573) answered multiple-choice questions based on a clinical case and variations of the case regarding laboratory and imaging evaluation, treatment choice, and follow-up. Results: The preferred initial treatment chosen by 95% of the respondents was ATD with a preferred treatment duration of 18-24 months. For 5% of the respondents, RAI was the initial treatment of choice. None of the respondents chose thyroidectomy. When presented with a patient with a desire for pregnancy in the near future, most respondents (69%) opted for ATD as the initial treatment. For a patient with signs of mild to moderate Graves' orbitopathy, ATD remained the initial therapy for 93.9% of the respondents. For patients initially treated with ATD with disease recurrence after ATD interruption, most respondents (60%) chose definitive treatment with RAI. A similar survey published in 2011 by Burch and cols. had results comparable to those of the present survey but with a higher proportion of respondents choosing RAI (45% in the 2011 survey versus 5% in the present survey). Conclusion: Brazilian endocrinologists choose ATD as the initial management of Graves' disease, and most choose RAI as a definitive treatment for a patient with relapse after ATD therapy.

6.
Arch. endocrinol. metab. (Online) ; 66(6): 871-882, Nov.-Dec. 2022. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1403245

ABSTRACT

ABSTRACT Primary hypothyroidism is a common disorder in clinical practice. The management of most cases of hypothyroidism is usually straightforward, but the best approach in some special situations may raise questions among physicians. This position statement was prepared by experts from the Brazilian Society of Endocrinology and Metabolism to guide the management of three special situations, namely, hypothyroidism in the elderly, subclinical hypothyroidism in patients with heart disease, and difficult-to-control hypothyroidism. The authors prepared the present statement after conducting a search on the databases MEDLINE/PubMed, LILACS, and SciELO and selecting articles with the best evidence quality addressing the selected situations. The statement presents information about the current approach to patients in these special situations.

7.
Braz. j. otorhinolaryngol. (Impr.) ; 88(supl.4): S163-S169, Nov.-Dec. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1420863

ABSTRACT

Abstract Objectives: This study aims to investigate if a sampling method using virtual networks is feasible to survey AS adoption among this "hard-to-reach" population of Brazilian doctors. Methods: An online piloted 11-point structured survey questionnaire (designed using Googleforms®) probed the actual treatment patterns for adult patients with PTMCs, including treatment decision-making nonoperative options, was undertaken between 10 November and 30 November 2020. Participants were reached by the mobile phone Application (APP) and a snowball sampling strategy was used to recruit a total of 4783 members (maximum number of potential reach), which is the total of doctors of the all 21 social media WhatsApp® groups. Results: From a total of 4783 members (maximum number of potential reach), there were 657 (13.7%) doctors (actual reach) who clicked the web link of the questionnaire, out of whom 512 (10.7%) fully completed the online survey. Among the survey respondents, 361 were endocrinologists (70.5%) and 151 were surgeons (29.5%). Overall, for low-risk PTMCs in an elderly patient, 118 responders (23%) recommend AS, while 390 (76%) recommend immediate surgery as the management, including lobectomy (18.5%) and Total Thyroidectomy (58.2%). The present responders tended to recommend surgery for PTMCs that were located adjacent to the dorsal surface of the thyroid, were multiple, or raised the size during the follow-up. Conclusion: Using snowball sampling strategy as an innovative route to conduct surveys was feasible and applicable but the rate of response was still very low. Our data also suggests the need to investigate if AS is embraced by Brazilian doctors.

8.
Rev. Ciênc. Méd. Biol. (Impr.) ; 21(3): 541-545, 20221229. tab
Article in Portuguese | LILACS | ID: biblio-1416268

ABSTRACT

Introdução: o envelhecimento populacional é um fenômeno universal devido ao processo de transição demográfica característico de diversos países. Nesse processo, observam-se alterações fisiológicas e nutricionais nos indivíduos, acompanhadas do declínio das atividades funcionais cotidianas. A Mini Avaliação Nutricional foi desenvolvida para detectar a desnutrição ou o risco nutricional. Trata ­ se de uma ferramenta simples, de fácil aplicação, efetiva e validada, para utilização em pacientes idosos. Objetivo: avaliar o estado nutricional através da aplicação da Mini Avaliação Nutricional (MAN) e fatores associados em idosos frequentadores da Universidade Aberta à Terceira Idade (UATI), situada em Salvador, Bahia. Metodologia: trata-se de um estudo observacional, analítico e de corte transversal, em que foram avaliados 52 idosos a partir de 60 anos, de ambos os sexos, admitidos entre os meses de fevereiro e junho de 2021. Na avaliação do estado nutricional, utilizou ­ se a MAN e, para a análise estatística, foi aplicado o programa Statistical Package for Social Science 20.0. A amostra foi categorizada em três grupos: adequado, risco de desnutrição e desnutrição. Utilizou-se o teste de qui quadrado, considerando p<0,05. Conclusão: os Resultados encontrados neste estudo mostram que há prevalência e um elevado risco de desnutrição nos pacientes idosos da UATI. Os grupos estudados se caracterizam por maior frequência do sexo feminino, faixa etária entre 60 e 69 anos, sem ocupação e com hipossuficiência financeira. A aplicação desse método de avaliação nutricional em idosos é de baixo custo e de fácil reprodutividade e tem demonstrado eficácia no rastreio da desnutrição de forma precoce, proporcionando intervenções nutricionais mais rápidas e efetivas, especialmente no contexto da saúde pública.


Introduction: population aging is a universal phenomenon due to the demographic transition process characteristic of several countries. In this process, physiological and nutritional changes are observed in individuals, accompanied by a decline in daily functional activities. The mini nutritional assessment was developed to detect malnutrition or nutritional risk. It is a simple, easy-to-apply, effective and validated tool for use in elderly patients. Objective: to evaluate the nutritional status through the application of the mini nutritional assessment (man) and associated factors in elderly people attending the universidade aberta à terceira idade (uati) [open university for the third age ­ elderly], located in salvador, bahia. Methods: this is an observational, analytical and cross-sectional study, in which 52 elderly people aged 60 years and over, of both sexes, admitted between february and june 2021, were evaluated. In the assessment of nutritional status, man was used and, for statistical analysis, the statistical package for social science 20.0 program was applied. The sample was categorized into three groups: adequate, risk of undernutrition and malnutrition. The chi-square test was used, considering p<0.05. Conclusion: the Results found in this study show that there is a prevalence and a high risk of malnutrition in elderly patients at the uati. The groups studied are characterized by a higher frequency of females, aged between 60 and 69 years, without occupation and with financial deficiency. The application of this method of nutritional assessment in the elderly is low-cost and easily reproducible and has been shown to be effective in screening for malnutrition at an early stage, providing faster and more effective nutritional interventions, especially in the context of public health.


Subject(s)
Humans , Male , Female , Aged , Aged , Aging , Nutrition Assessment , Nutritional Status , Health of the Elderly , Malnutrition , Laboratory and Fieldwork Analytical Methods , Cross-Sectional Studies
9.
Endocr Connect ; 11(10)2022 Oct 01.
Article in English | MEDLINE | ID: mdl-36040475

ABSTRACT

Introduction: The severity of coronavirus disease 2019 (COVID-19) has been positively correlated with several comorbidities. The primary outcome of the study was to assess the relationship between the mortality and severity of COVID-19 and obesity classes according to BMI, visceral adipose tissue (VAT) area, s.c. adipose tissue area, muscle area (MA), and leptin levels. Methods: In this prospective cohort study, 200 patients hospitalized with moderate-to-severe COVID-19 underwent an unenhanced CT of the thorax and laboratory tests, and leptin levels between June and August 2020 were obtained. Results: Our study included 200 patients (male 52%; mean age: 62 (49-74) years; obesity (BMI > 30): 51.5%)). Fifty-eight patients (23.5%) were admitted to the intensive care unit and 29 (14.5%) died. In multivariate logistic regression (corrected for leptin, sex, age, and serum biomarkers) and receiver operating characteristic curve analyses, high VAT > 150 cm2 (odds ratio (OR): 6.15; P < 0.002), MA < 92 cm2 (OR: 7.94; P < 0.005), and VAT/MA ratio > 2 (OR: 13.9; P < 0.0001) were independent risk factors for mortality. Indeed, the Kaplan-Meier curves showed that patients with MA < 92 cm2 and without obesity (BMI < 30) had a lower survival rate (hazard ratio between 3.89 and 9.66; P < 0.0006) than the other groups. Leptin levels were not related to mortality and severity. Conclusion: This prospective study reports data on the largest number of hospitalized severe COVID-19 patients and pinpoints VAT area and MA calculated by CT as predictors of COVID-19 mortality.

10.
EBioMedicine ; 82: 104137, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35785619

ABSTRACT

BACKGROUND: The diagnosis of cancer in Bethesda III/IV thyroid nodules is challenging as fine-needle aspiration (FNA) has limitations, and these cases usually require diagnostic surgery. As approximately 77% of these nodules are not malignant, a diagnostic test accurately identifying benign thyroid nodules can reduce "potentially unnecessary" surgery rates. We have previously reported the development and validation of a microRNA-based thyroid classifier (mir-THYpe) with high sensitivity and specificity, which could be performed directly from FNA smear slides. We sought to evaluate the performance of this test in real-world clinical routine to support clinical decisions and to reduce surgery rates. METHODS: We designed a real-world, prospective, multicentre study. Molecular tests were performed with FNA samples prepared at 128 cytopathology laboratories. Patients were followed-up from March 2018 until surgery or until March 2020 (patients with no indication for surgery). The final diagnosis of thyroid tissue samples was retrieved from postsurgical anatomopathological reports. FINDINGS: A total of 435 patients (440 nodules) classified as Bethesda III/IV were followed-up. The rate of avoided surgeries was 52·5% for all surgeries and 74·6% for "potentially unnecessary" surgeries. The test achieved 89·3% sensitivity, 81·65% specificity, 66·2% positive predictive value, and 95% negative predictive value. The test supported 92·3% of clinical decisions. INTERPRETATION: The reported data demonstrate that the use of the microRNA-based classifier in the real-world can reduce the rate of thyroid surgeries with robust performance and support clinical decision-making. FUNDING: The São Paulo Research-Foundation (FAPESP) and Onkos.


Subject(s)
Decision Support Systems, Clinical , MicroRNAs , Thyroid Neoplasms , Thyroid Nodule , Brazil , Humans , MicroRNAs/genetics , Prospective Studies , Retrospective Studies , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/genetics , Thyroid Neoplasms/surgery , Thyroid Nodule/diagnosis , Thyroid Nodule/genetics , Thyroid Nodule/pathology
11.
Endocrine ; 77(3): 486-492, 2022 09.
Article in English | MEDLINE | ID: mdl-35678976

ABSTRACT

INTRODUCTION: The subjective evaluation of nuclear features in follicular-patterned lesions of the thyroid is a reason for diagnosis discordance. The assessment of nuclear features also varies whether the observation is performed optically or digitally. Our objective was to study the concordance among pathologists regarding the nuclear score (NS) evaluation in a series of follicular-patterned lesions, using optical versus three digital scanning protocols. METHODS: Three pathologists evaluated the NS in a 3mm2 area randomly selected from 20 hematoxylin-eosin slides representative of the respective 20 follicular-patterned thyroid lesions. The NS evaluation was performed using optical and three different scanning protocols in two scanners: P1000_20x, P1000_40x and DP200_20x. Kappa statistic (κ) and intraclass correlation coefficient (ICC) were obtained for intra- and interpathologist concordance. RESULTS: We recorded a good agreement among pathologists in the optical evaluation of the NS (ICC of 0.73). The concordance between optical versus digital observation had an almost perfect agreement for P1000_20x [κ = 0.85 (0.67-1.02); p < 0.0001] and a substantial agreement for both P1000_40x [κ = 0.69 (0.43-0.95) p = 0.002] and DP200_20x [κ = 0.77 (0.57-0.97); p = 0.001]. The P1000_20x protocol had the best intrapathologist concordance with the optical method, classified as almost perfect agreement for pathologists A (80%) and B (85%), and substantial agreement for pathologist C (70%). CONCLUSION: Digital observation of the WSI is valid for the NS evaluation in follicular-patterned thyroid lesions, with good agreement among pathologists and between optical and scanning protocols. Performance studies and validation procedures cannot be avoided in this setting to prevent diagnostic discordance due to the scanning process.


Subject(s)
Cell Nucleus , Thyroid Gland , Cell Nucleus/pathology , Humans , Observer Variation , Thyroid Gland/diagnostic imaging , Thyroid Gland/pathology
12.
Braz J Otorhinolaryngol ; 88 Suppl 4: S163-S169, 2022.
Article in English | MEDLINE | ID: mdl-35177356

ABSTRACT

OBJECTIVES: This study aims to investigate if a sampling method using virtual networks is feasible to survey AS adoption among this "hard-to-reach" population of Brazilian doctors. METHODS: An online piloted 11-point structured survey questionnaire (designed using Googleforms®) probed the actual treatment patterns for adult patients with PTMCs, including treatment decision-making nonoperative options, was undertaken between 10 November and 30 November 2020. Participants were reached by the mobile phone Application (APP) and a snowball sampling strategy was used to recruit a total of 4783 members (maximum number of potential reach), which is the total of doctors of the all 21 social media WhatsApp® groups. RESULTS: From a total of 4783 members (maximum number of potential reach), there were 657 (13.7%) doctors (actual reach) who clicked the web link of the questionnaire, out of whom 512 (10.7%) fully completed the online survey. Among the survey respondents, 361 were endocrinologists (70.5%) and 151 were surgeons (29.5%). Overall, for low-risk PTMCs in an elderly patient, 118 responders (23%) recommend AS, while 390 (76%) recommend immediate surgery as the management, including lobectomy (18.5%) and Total Thyroidectomy (58.2%). The present responders tended to recommend surgery for PTMCs that were located adjacent to the dorsal surface of the thyroid, were multiple, or raised the size during the follow-up. CONCLUSION: Using snowball sampling strategy as an innovative route to conduct surveys was feasible and applicable but the rate of response was still very low. Our data also suggests the need to investigate if AS is embraced by Brazilian doctors.


Subject(s)
Thyroid Neoplasms , Adult , Humans , Aged , Thyroid Neoplasms/surgery , Watchful Waiting , Thyroidectomy , Brazil
13.
J Clin Endocrinol Metab ; 107(6): e2488-e2501, 2022 05 17.
Article in English | MEDLINE | ID: mdl-35137147

ABSTRACT

CONTEXT: The type 2 deiodinase and its Thr92Ala-DIO2 polymorphism have been linked to clinical outcomes in acute lung injury and pulmonary fibrosis. OBJECTIVE: Our objectives were to evaluate were cumulative mortality during admission according to Thr92Ala-DIO2 polymorphism. METHODS: Here we conducted an observational, longitudinal, and prospective cohort study to investigate a possible association between the Thr92Ala-DIO2 polymorphism and intrahospital mortality from COVID-19 in adult patients admitted between June and August 2020. Blood biochemistry, thyroid function tests, length of stay, comorbidities, complications, and severity scores were also studied according to Thr92Ala-DIO2 polymorphism. RESULTS: In total, 220 consecutive patients (median age 62; 48-74 years) were stratified into 3 subgroups: Thr/Thr (n = 79), Thr/Ala (n = 119), and Ala/Ala (n = 23). While the overall mortality was 17.3%, the lethality was lower in Ala/Thr patients (12.6%) than in Thr/Thr patients (21.7%) or Ala/Ala patients (23%). The heterozygous genotype (Thr/Ala) was associated with a 47% reduced risk of intrahospital mortality whereas univariate and multivariate logistic regression adjusted for multiple covariates revealed a reduction that ranged from 51% to 66%. The association of the Thr/Ala genotype with better clinical outcomes was confirmed in a metanalysis of 5 studies, including the present one. CONCLUSION: Here we provide evidence for a protective role played by Thr92Ala-DIO2 heterozygosity in patients with COVID-19. This protective effect follows an inheritance model known as overdominance, in which the phenotype of the heterozygote lies outside the phenotypical range of both homozygous.


Subject(s)
COVID-19 , Iodide Peroxidase , COVID-19/genetics , COVID-19/mortality , Heterozygote , Hospital Mortality , Humans , Iodide Peroxidase/genetics , Longitudinal Studies , Polymorphism, Single Nucleotide , Prospective Studies , Iodothyronine Deiodinase Type II
14.
Front Endocrinol (Lausanne) ; 13: 1041676, 2022.
Article in English | MEDLINE | ID: mdl-36601011

ABSTRACT

Coronavirus disease 2019 (COVID-19) was characterized as a pandemic in March, 2020 by the World Health Organization. COVID-19 is a respiratory syndrome that can progress to acute respiratory distress syndrome, multiorgan dysfunction, and eventually death. Despite being considered a respiratory disease, it is known that other organs and systems can be affected in COVID-19, including the thyroid gland. Thyroid gland, as well as hypothalamus and pituitary, which regulate the functioning of most endocrine glands, express angiotensin-converting enzyme 2 (ACE2), the main protein that functions as a receptor to which SARS-CoV-2 binds to enter host cells. In addition, thyroid gland is extremely sensitive to changes in body homeostasis and metabolism. Immune system cells are targets for thyroid hormones and T3 and T4 modulate specific immune responses, including cell-mediated immunity, natural killer cell activity, the antiviral action of interferon (IFN) and proliferation of T- and B-lymphocytes. However, studies show that patients with controlled hypothyroidism and hyperthyroidism do not have a higher prevalence of COVID-19, nor do they have a worse prognosis when infected with the virus. On the other hand, retrospective observational studies, prospective studies, and case reports published in the last two years reported abnormal thyroid function related to acute SARS-CoV-2 infection or even several weeks after its resolution. Indeed, a variety of thyroid disorders have been documented in COVID-19 patients, including non-thyroidal illness syndrome (NTIS), subacute thyroiditis and thyrotoxicosis. In addition, thyroid disease has already been reported as a consequence of the administration of vaccines against SARS-CoV-2. Overall, the data revealed that abnormal thyroid function may occur during and in the convalescence post-COVID condition phase. Although the cellular and molecular mechanisms are not completely understood, the evidence suggests that the "cytokine storm" is an important mediator in this context. Thus, future studies are needed to better investigate the pathophysiology of thyroid dysfunction induced by COVID-19 at both molecular and clinical levels.


Subject(s)
COVID-19 , Thyroid Diseases , Humans , SARS-CoV-2/metabolism , COVID-19 Vaccines , Prospective Studies , Retrospective Studies , Peptidyl-Dipeptidase A/metabolism , Thyroid Diseases/complications , Thyroid Diseases/epidemiology
15.
Rev. Ciênc. Méd. Biol. (Impr.) ; 20(3): 447-453, dez 20, 2021. tab
Article in Portuguese | LILACS | ID: biblio-1354294

ABSTRACT

Introdução: o processo de envelhecimento tem sido constante objeto de estudos epidemiológicos, em função do recrudescimento do número de idosos na população, resultando numa incessante busca de instituições de longa permanência. O uso de métodos de avaliação nutricional e de composição corporal em idosos dessas instituições pode ser considerado um diferencial na assistência multimodal. Objetivo: avaliar a composição corporal de idosos institucionalizados por meio da Absortometria Radiológica de Dupla Energia, atendidos do Hospital Santo Antônio, na cidade de Salvador, Bahia. Metodologia: estudo descritivo, analítico, corte transversal, com 13 idosos de ambos os sexos da referida instituição. Aplicou-se questionário sociodemográfico e de dados clínicos e os idosos foram submetidos a DXA, obedecendo a protocolos padrão para realização do exame. Resultados: predominância do sexo feminino (61%) e idade média de 79,5 (DP=7,0). As mulheres se destacaram por excesso de gordura corporal (61,5%) e, no que tange à reserva de massa muscular, a distribuição percentual e absoluta foi dividida de forma igual para ambos os sexos (50%). Conclusões: foi possível observar que grande parte dos idosos avaliados, e em especial mulheres, apresentou excesso de tecido corporal gorduroso, considerando todas as variáveis relacionadas à massa gordurosa corporal reveladas pela DXA. Estudos dentro dessa temática, no último ciclo de vida mais vulnerável são de suma importância, uma vez que o número populacional de idosos tem assumido nos últimos anos um crescimento exponencial.


Introduction: the aging process has been a constant object of epidemiological studies, due to the increase in the number of elderly people in the population, resulting in an incessant search for long-term care facilities. The use of methods for nutritional assessment of body composition in the elderly in these institutions can be considered a differential in multimodal care. Objective: assessing the body composition of elderly institutionalized people using dual energy X-ray absorptiometry at Santo Antônio Hospital, in the city of Salvador, Bahia. Methodology: descriptive, analytical, cross-sectional study with 13 elderly people male and female from that institution. A sociodemographic and clinical data questionnaire was applied and the elderly were submitted to DXA, following standard protocols for the examination. Results: prevalence of females (61%) and mean age of 79.5 (SD=7.0). Women stood out due to excess body fat (61.5%) and, with regard to muscle mass reserve, the percentage and absolute distribution was equally divided for men and women (50%). Conclusion: it was possible to observe that most of the elderly evaluated, and especially women, had excess body fat tissue, considering all variables related to body fat mass revealed by DXA. Studies into this theme are crucial in the last most vulnerable life cycle, since the number of elderly population has assumed an exponential growth in recent years.


Subject(s)
Humans , Male , Female , Aged , Body Composition , Aged , Aging , Health of Institutionalized Elderly , Laboratory and Fieldwork Analytical Methods , Epidemiology, Descriptive , Cross-Sectional Studies
16.
Rev. Ciênc. Méd. Biol. (Impr.) ; 20(3): 472-475, dez 20, 2021. fig
Article in Portuguese | LILACS | ID: biblio-1354351

ABSTRACT

Introdução: o carcinoma papilífero de tireoide é a neoplasia maligna que mais acomete o sistema endócrino, correspondendo a cerca de 90% dos casos. Diante de sua frequência, nas últimas décadas, foi registrado um aumento do número de casos na população pediátrica e, devido a isso, o número de crianças e adolescentes submetidos à tireoidectomia se tornou cada vez maior. Enquanto as alterações gênicas mais encontradas em adultos com carcinoma papilífero concentram-se em mutações pontuais, na população pediátrica as fusões gênicas são mais frequentes, com destaque para os rearranjos RET/PTC. Objetivo: relatar aspectos clínico-patológicos do carcinoma papilífero de tireoide, associado à fusão do gene RET, em criança submetida à tireoidectomia e radioiodoterapia adjuvante. Em seguida, discute-se a importância do diagnóstico molecular na escolha de terapias relevantes no tratamento do CPT. Caso Clínico: trata-se de uma paciente do sexo feminino, 11 anos de idade, submetida a tireoidectomia total e esvaziamento cervical após diagnóstico do referido carcinoma. O estudo anatomopatológico revelou um carcinoma metastático em linfonodos regionais. Utilizou-se uma amostra de tecido em bloco de parafina para a realização de um sequenciamento de nova geração, que apontou a existência da fusão gênica TRIM24-RET. Conclusão: os dados deste relato de caso evidenciam que a mutação RET/PTC6 está muito associada à população pediátrica e que testes moleculares, como o NGS, são de extremo valor na identificação dessas alterações gênicas e, consequentemente, na terapia a ser adotada para cada paciente.


Introduction: thyroid papillary carcinoma is the malignant neoplasm that most affects the endocrine system, corresponding to about 90% of cases. Given its frequency, in recent decades, there has been an increase in the number of cases in the pediatric population and, as a result, the number of children and adolescents undergoing thyroidectomy has become increasingly larger. While the most common gene alterations found in adults with papillary carcinoma are concentrated in point mutations, in the pediatric population gene fusions are more frequent, with emphasis on the RET/PTC rearrangements. Objective: to report clinical and pathological aspects of papillary thyroid carcinoma associated with RET gene fusion in a child undergoing thyroidectomy and adjuvant radioiodine therapy. Then, the importance of molecular diagnosis in choosing relevant therapies in the treatment of PTC is discussed. Clinical Case: this is an 11-year-old female patient who underwent total thyroidectomy and neck dissection after diagnosis of the aforementioned carcinoma. The anatomopathological study revealed a metastatic carcinoma in regional lymph nodes. A tissue sample in paraffin block was used to perform a new generation sequencing, which showed the existence of the TRIM24-RET gene fusion. Conclusion: the data in this case report show that the RET/PTC6 mutation is closely associated with the pediatric population and that molecular tests, such as the NGS, are extremely valuable in identifying these genetic alterations and, consequently, in the therapy to be adopted for each patient.


Subject(s)
Humans , Female , Child , Thyroidectomy , Translocation, Genetic , Child , Thyroid Cancer, Papillary
18.
Rev. Ciênc. Méd. Biol. (Impr.) ; 20(3): 480-484, dez 20, 2021. fig
Article in Portuguese | LILACS | ID: biblio-1354354

ABSTRACT

Introdução: o gene TERT codifica a subunidade catalítica da telomerase responsável pelo alongamento dos telômeros no final dos cromossomos. Mutações na região promotora do gene TERT resultam em superexpressão da subunidade catalítica e promovem aumento da atividade da telomerase, fatos que levam ao aumento da incidência do câncer. No carcinoma anaplásico da tireoide, essas mutações são preditores de pior prognóstico e estão associadas a comportamento clínico agressivo, incluindo alta frequência de recidivas, metástases a distância e morte específica pela doença. Objetivo: relatar o caso de uma paciente idosa portadora de carcinoma anaplásico da tireoide, cujo teste de sequenciamento genético revelou a mutação do promotor TERT C228T. Caso clínico: mulher idosa, 66 anos, diagnosticada inicialmente com nódulo tireoidiano, o qual cresceu rapidamente em um curto período de tempo. Diante da suspeita de neoplasia maligna, a paciente foi submetida a tireoidectomia total, com realização de esvaziamento cervical. Os estudos anatomopatológico e imuno-histoquímico do tumor confirmaram o carcinoma. Estudos moleculares realizados a partir da tecnologia do sequenciamento de nova geração negaram a presença de fusões gênicas, porém detectaram a mutação TERT C228T. Discussão: a identificação da mutação no promotor TERT C288T reforça a hipótese de que mutações TERT são frequentes em tumores tireoidianos mais agressivos, como é o caso do carcinoma anaplásico da tireoide. Conclusão: os dados apresentados neste estudo reforçam a premissa de que mutações no promotor TERT são preditores de pior prognóstico e de comportamento clínico mais agressivo.


Introduction: the TERT gene encodes the catalytic telomerase subunit responsible for elongating telomeres at the end of chromosomes. Mutations in the promoter region of the TERT gene result in overexpression of the catalytic subunit and promote increased telomerase activity, facts that lead to an increased incidence of cancer. In anaplastic thyroid carcinoma, these mutations are predictors of worse prognosis and are associated with aggressive clinical behavior, including a high frequency of relapses, distant metastases, and diseasespecific death. Objective: to report the case of an elderly patient with anaplastic thyroid carcinoma, whose gene sequencing test revealed a TERT C228T promoter mutation. Case report: Elderly woman, 66 years old, initially diagnosed with a thyroid nodule, which grew rapidly in a short period of time. Given the suspicion of malignant neoplasm, the patient underwent total thyroidectomy, with neck dissection. The anatomopathological and immunohistochemical studies of the tumor confirmed the carcinoma. Molecular studies performed using next-generation sequencing technology denied the presence of gene fusions, but detected the TERT C228T mutation. Discussion: identification of the mutation in the TERT C288T promoter reinforces the hypothesis that TERT mutations are frequent in more aggressive thyroid tumors, such as anaplastic thyroid carcinoma. Conclusion: data presented in this study reinforce the premise that mutations in the TERT promoter are predictors of worse prognosis and more aggressive clinical behavior.


Subject(s)
Humans , Female , Aged , Thyroidectomy , Telomerase , Thyroid Carcinoma, Anaplastic , Mutation , Genes
19.
Front Endocrinol (Lausanne) ; 12: 671784, 2021.
Article in English | MEDLINE | ID: mdl-34447350

ABSTRACT

Congenital hypothyroidism (CH) is an endocrine disease commonly found in newborns and is related to the absence or reduction of thyroid hormones (THs), which are essential for development since intrauterine life. Children with CH can develop hearing problems as THs are crucial for the auditory pathway's development and maturation. Sensory deprivations, especially in hearing disorders at early ages of development, can impair language skills, literacy, and behavioral, cognitive, social, and psychosocial development. In this review we describe clinical and molecular aspects linking CH and hearing loss.


Subject(s)
Congenital Hypothyroidism/complications , Hearing Loss/etiology , Hearing/physiology , Language Disorders/etiology , Language , Child , Congenital Hypothyroidism/physiopathology , Hearing Loss/physiopathology , Humans , Language Disorders/physiopathology
20.
Endocr Relat Cancer ; 28(9): R217-R230, 2021 09 01.
Article in English | MEDLINE | ID: mdl-34378152

ABSTRACT

Differentiated thyroid carcinoma (DTC) combined with congenital hypothyroidism (CH) is a rare situation, and there is no well-established causal relationship. CH is a common congenital endocrine, while DTC occurring in childhood represents 0.4-3% of all malignancies at this stage of life. The association of CH with DTC could be related to dyshormonogenetic goiter (DHG) or developmental abnormalities. This review will explore the clinical features and the molecular mechanisms potentially associated with the appearance of DTC in CH: sporadic somatic driver mutations, chronic increase of thyroid-stimulating hormone (TSH) levels, higher concentrations of hydrogen peroxide (H2O2), cell division cycle associated 8 (Borelain/CDC8) gene mutations, and in others genes associated with CH - either alone or associated with the mechanisms involved in dyshormonogenesis. There are some pitfalls in the diagnosis of thyroid cancer in patients with CH with nodular goiter, as the proper cytological diagnosis of nodules of patients with dyshormonogenesis might be demanding due to the specific architectural and cytological appearance, which may lead to an erroneous interpretation of malignancy. The purpose of this article is to suggest an analytical framework that embraces the fundamental relationships between the various aspects of CH and CDT. In face of this scenario, the entire genetic and epigenetic context, the complex functioning, and cross talk of cell signaling may determine cellular mechanisms promoting both the maintenance of the differentiated state of the thyroid follicular cell and the disruption of its homeostasis leading to cancer. Whereas, the exact mechanisms for thyroid cancer development in CH remain to be elucidated.


Subject(s)
Congenital Hypothyroidism , Thyroid Neoplasms , Congenital Hypothyroidism/diagnosis , Congenital Hypothyroidism/genetics , Congenital Hypothyroidism/metabolism , Humans , Hydrogen Peroxide , Mutation , Thyroid Neoplasms/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...